A biotech company Niklason founded, called Humacyte, has begun animal testing on arteries grown this way.

The stem-cell treatment Revascor is injected into the artery during the angioplasty to prevent damage to the heart, using the healing properties of stem cells.

A new way to curb inflammatory cells could lead to treatments for diseases including atherosclerosis and cancer.